Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

19.33

-0.17 (-0.87%)

At close: Sep 23, 2026, 4:00 PM EDT

19.40

+0.07 (0.36%)

Pre-market: Sep 24, 2026, 8:05 AM EDT

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,733	3,961	2,454	1,861	301	715
Market Cap Growth	118.51%	61.41%	31.88%	517.29%	-57.87%	6.05%
Enterprise Value	9,393	6,511	5,081	4,434	2,989	3,372
Last Close Price	19.33	12.60	7.92	6.07	1.99	4.79

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	40.20	54.97	-	-	-	67.35
Forward PE	19.24	15.04	11.69	11.92	2.71	5.65
PS Ratio	2.16	1.31	0.88	0.78	0.14	0.34
PB Ratio	186.91	664.26	-55.10	30.35	1.44	1.86
P/FCF Ratio	81.01	16.43	10.45	6.23	18.49	3.75
P/OCF Ratio	33.53	11.65	8.32	5.38	4.63	2.96
PEG Ratio	2.14	0.51	0.51	0.51	0.18	0.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.01	2.16	1.82	1.85	1.35	1.61
EV/EBITDA Ratio	13.62	10.11	8.69	9.05	6.79	7.49
EV/EBIT Ratio	18.97	15.48	14.59	17.03	14.94	15.57
EV/FCF Ratio	113.02	27.00	21.64	14.84	183.29	17.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	23.87	450.96	-58.22	44.87	13.62	7.52
Debt / EBITDA Ratio	3.94	4.06	4.31	5.43	6.15	6.15
Debt / FCF Ratio	33.59	11.15	11.05	9.21	174.50	15.13
Net Debt / Equity Ratio	22.74	402.92	-55.70	43.34	13.49	6.87
Net Debt / EBITDA Ratio	3.86	3.73	4.24	5.42	6.40	5.86
Net Debt / FCF Ratio	32.01	9.96	10.57	8.89	172.79	13.82
Asset Turnover	0.87	0.84	0.80	0.66	0.57	0.53
Inventory Turnover	2.92	3.10	2.98	2.77	2.79	2.67
Quick Ratio	1.38	1.39	0.82	0.87	1.10	1.39
Current Ratio	2.21	2.17	1.41	1.63	1.88	2.25
Return on Equity (ROE)	613.02%	-	-881.26%	-36.06%	-85.96%	5.45%
Return on Assets (ROA)	8.60%	7.32%	6.24%	4.48%	3.23%	3.41%
Return on Invested Capital (ROIC)	18.64%	16.18%	13.69%	9.07%	6.61%	4.62%
Return on Capital Employed (ROCE)	17.10%	15.00%	14.70%	9.90%	6.60%	6.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.34%	1.82%	-4.76%	-4.51%	-43.12%	1.49%
FCF Yield	1.23%	6.09%	9.57%	16.06%	5.41%	26.68%
Buyback Yield / Dilution	-3.48%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%
Total Shareholder Return	-3.48%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%

SEC Filings: 10-K · 10-Q